q25. what are the risks of unmonitored antagonization of neuromuscular block?
Published 1 year ago • 51 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
6:08
q21. what are the most common pitfalls in neuromuscular blockade management?
-
4:39
neuromuscular blocking agents
-
3:25
q7. what are the risks of facial nerve monitoring?
-
3:50
q11. what are the highlights of europe esaic 2023 guidelines on management of neuromuscular blockade
-
2:01
q9. which muscles are more resistant to neuromuscular blocking agents?
-
2:17
q5. what are the key points of the uk aagbi 2021 guidelines on management of neuromuscular blockade?
-
1:11
q4. what are the key points of the belgium sarb 2019 guidelines on management of neuromuscular block
-
11:43
dr grant rodney and objective neuromuscular block monitoring
-
1:52
q24. how dependable is the time since my last dose of relaxant to determine the time of extubation?
-
3:26
train of four monitoring using the ulnar nerve
-
58:46
neuromuscular block monitoring
-
5:43
qd 62 - the problem with pain
-
18:39
rsv: omnipresent and inescapable
-
19:38
2.3 hrv in cardiology: clinical evidence & hrv in diabetic autonomic neuropathy
-
44:12
ep157 neuromuscular disease for emergency medicine
-
0:25
neurologist_q14_what are the parameters that can be adjusted and what are the effects of this